Literature DB >> 9776422

Alkalinization and hemodialysis in severe salicylate poisoning: comparison of elimination techniques in the same patient.

R M Higgins1, J O Connolly, B M Hendry.   

Abstract

We report the case of a man who took two overdoses of aspirin, on each occasion suffering a grand mal fit with blood levels of salicylate of over 5 mmol/l. The first event was treated with hemodialysis but without effective alkalinization, and the second with alkalinization but without hemodialysis. The rate of decline in salicylate concentration was faster with alkalinization in the first 4 hours. Similar salicylate levels were achieved with both techniques by 24 hours post-overdose. If a case of salicylate poisoning is to be treated with hemodialysis, treatment with alkalinization should still be given without delay, in order to prevent acidemia and to promote elimination of as much salicylate as possible via the kidneys.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9776422

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  4 in total

1.  An evidence based flowchart to guide the management of acute salicylate (aspirin) overdose.

Authors:  P I Dargan; C I Wallace; A L Jones
Journal:  Emerg Med J       Date:  2002-05       Impact factor: 2.740

2.  Severe salicylate poisoning treated conservatively.

Authors:  Sandeep Basavarajaiah; Paul Sigston; Kuno Budack
Journal:  J R Soc Med       Date:  2004-12       Impact factor: 18.000

Review 3.  Management of toxic ingestions with the use of renal replacement therapy.

Authors:  Timothy E Bunchman; Maria E Ferris
Journal:  Pediatr Nephrol       Date:  2010-10-12       Impact factor: 3.714

Review 4.  Acetylsalicylic acid as a potential pediatric health hazard: legislative aspects concerning accidental intoxications in the European Union.

Authors:  Menen E Mund; Christoph Gyo; Dörthe Brüggmann; David Quarcoo; David A Groneberg
Journal:  J Occup Med Toxicol       Date:  2016-07-13       Impact factor: 2.646

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.